Support for targeted therapy selection in triple negative breast cancer patients using aberrant signal transduction pathway activity profiles

Keizer, DM; Wesseling, YJ; Van Strijp, DA; Vermeer, SM; den Biezen, EC

CANCER RESEARCH, 2023; 83 (7):